These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 1724843
1. [Role of steroid hormones and related biological substances in the etiology of endometrial carcinomas]. Lang-Avérous G, Rupp K, Wehner H, Dallenbach-Hellweg G. Verh Dtsch Ges Pathol; 1991; 75():366-9. PubMed ID: 1724843 [Abstract] [Full Text] [Related]
6. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)]. Ivanova V, Karaivanov M, Marinov E, Gorchev G, Velkova A, Khristova P. Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005 [Abstract] [Full Text] [Related]
7. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T. Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450 [Abstract] [Full Text] [Related]
9. Effects of hormone therapy on the endometrium. Deligdisch L. Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860 [Abstract] [Full Text] [Related]
10. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Hauth E, Libera H, Kimmig R, Forsting M. Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840 [Abstract] [Full Text] [Related]
11. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy]. Krause A, Gerber B. Zentralbl Gynakol; 1994 Mar; 116(1):44-7. PubMed ID: 8147180 [Abstract] [Full Text] [Related]
13. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Dibi RP, Zettler CG, Pessini SA, Ayub AV, de Almeida SB, da Silveira GP. Menopause; 2009 Mar; 16(2):293-300. PubMed ID: 19034048 [Abstract] [Full Text] [Related]
15. Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (tamoxifen) and gestagens. Dallenbach-Hellweg G, Hahn U. Int J Gynecol Pathol; 1995 Jan; 14(1):7-15. PubMed ID: 7883429 [Abstract] [Full Text] [Related]
16. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology. Kennedy MM, Baigrie CF, Manek S. Int J Gynecol Pathol; 1999 Apr; 18(2):130-7. PubMed ID: 10202670 [Abstract] [Full Text] [Related]
17. [Endometrial cancers arising in polyps associated with tamoxifen use]. Mbatsogo BA, Le Bouëdec G, Michy T, Bourdel N, Fouilloux G, Dauplat J. Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556 [Abstract] [Full Text] [Related]
18. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Cheng WF, Lin HH, Torng PL, Huang SC. Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568 [Abstract] [Full Text] [Related]
19. [Histological analysis of endometrial polyps in breast cancer patients treated with tamoxifen (nolvadex)]. Ivanova V, Karaivanov M, Raĭcheva S, Marinov E, Gorchev G. Akush Ginekol (Sofiia); 2004 Aug; 43(2):33-6. PubMed ID: 15185527 [Abstract] [Full Text] [Related]
20. Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen. Dal Cin P, Timmerman D, Van den Berghe I, Wanschura S, Kazmierczak B, Vergote I, Deprest J, Neven P, Moerman P, Bullerdiek J, Van den Berghe H. Cancer Res; 1998 Jun 01; 58(11):2278-81. PubMed ID: 9622058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]